BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:d3988b04-b6cf-48c5-8280-e8d28e617ab9
DTSTAMP:20250908T160018Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:a34ceb24-c307-4012-94ce-478b72fba0ab
DTSTAMP:20250908T160018Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:1fe9d971-ed48-418b-b50d-13b7dcdee695
DTSTAMP:20250908T160018Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:15fa400f-6c42-46df-aa63-cc1c88885ad6
DTSTAMP:20250908T160018Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:4584d532-fd0f-42c3-a544-b3443634991c
DTSTAMP:20250908T160018Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:e1b340ef-6b4c-4732-a126-1b485c87d4ce
DTSTAMP:20250908T160018Z
DTSTART:20251021T090000Z
DTEND:20251021T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:be91f08e-d572-452d-b6f1-1e2b808946fd
DTSTAMP:20250908T160018Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:74af3588-583c-4f0f-8d76-02181e71984c
DTSTAMP:20250908T160018Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:aba4e653-3184-4866-bc4e-8a4bb6ce3f28
DTSTAMP:20250908T160018Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:0b3f7e17-fb45-4fb1-89c4-4d98d8bc1584
DTSTAMP:20250908T160018Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:87575b00-c282-4149-b879-538ab5bbebf6
DTSTAMP:20250908T160018Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:afe16809-3bc6-4630-8ed2-7176f2d88f21
DTSTAMP:20250908T160018Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:e5a16898-8c70-400a-8197-d167929f268d
DTSTAMP:20250908T160018Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:01d468a2-992c-46ed-ab5d-4769f0198b4b
DTSTAMP:20250908T160018Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:3d24d62c-5ec0-49c5-af6e-4da5a9943757
DTSTAMP:20250908T160018Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:3fda7be9-b122-45de-9168-187014065e49
DTSTAMP:20250908T160018Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - ?Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:0a391124-713f-4ea0-9c6a-c687c6fd2730
DTSTAMP:20250908T160018Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:1dae086b-af21-43ea-9d40-e7753ca9b535
DTSTAMP:20250908T160018Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:27f72032-e905-402e-adcd-f6950485be1e
DTSTAMP:20250908T160018Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
END:VCALENDAR
